Hospitals’ Strong December Caps A Year Of Rising Operating Margins

The past year was a step in the right direction for the hospital industry as outpatient revenue and below-inflation expense increases fueled a 9% year-over-year increase in 12-month operating margins.

The new numbers from advisory firm Kaufman Hall run through December and reflect operating data from 1,300 hospitals nationwide as collected by Strata.

Those hospitals logged a collective 4.9% median operating margin across the year and ended on a strong note with a 7.6% median operating margin for December alone.

Full-year adjusted discharges per calendar day rose 5% from 2023 to 2024, while average length of stay fell 1%, ED visits grew 1% and observation patient days comprised a 13% smaller portion of total patient days.

Through 2024, hospitals’ daily net operating revenue grew 8%, inpatient revenue by 8% and outpatient revenue by 9% as compared to the year prior. Net patient service revenue per adjusted discharge rose 3%, and net patient service revenue per adjusted patient day rose by 5%.

In comparison, full-year daily total expenses rose 6% year over year, with labor rising by 5%, nonlabor by 7%, supply expenses by 9%, drug expenses by 9% and purchased service expenses by 8%. Total expense per adjusted discharge increased by 2% year over year with nonlabor expenses pushing more of the growth.

Focusing in on single-month performance, daily net revenue grew 2% month over month and 6% when comparing December 2024 to December 2023. Inpatient revenues were up 4% and 5% for those same comparisons while outpatient shifted by 0% and 10%.

Conversely, hospitals’ daily total expenses were flat from November to December and rose 6% from December 2023 to December 2024.

The numbers broadly spell good news for the hospital sector, though the firm was quick to point out hospitals’ recent road bumps and other trends worth keeping an eye on, such as a 14% rise in bad debt and charity from 2023 to 2024.

“While it’s encouraging to see continued stability in hospitals’ financial well-being over the past 12 months, historically slim margins indicate hospitals are not yet in a fully sustainable position,” Erik Swanson, senior vice president and data and analytics group leader with Kaufman Hall, said in a release. “The uptick in bad debt and levels of uncompensated care provided by hospitals will be an indicator to monitor over the next several months. On the workforce front, we continue to see a competitive and tight labor market across the healthcare sector.”

Looking ahead to the new year, Swanson previously told Fierce Healthcare to keep an eye out for continued outpatient growth, supply and drug cost inflation (particularly with the looming threat of tariffs) and a divide between top and bottom performers that could fuel M&A.

 

Source Link

Recommended Articles

CMS Finalizes Major Changes To ACA Exchanges, Including Greater Access To Catastrophic Plans

Editor’s Note: Covered California is a State-Based Marketplace (SBM). For details on how these new rules will impact Covered California and other SBMs we recommend the following Princeton University linked report: (Broker rule changes appear at the bottom of the Princeton analysis.) https://shvs.org/wp-content/uploads/2025/06/SHVS_2025-Final-Marketplace-Integrity-Rule.pdf.   The Trump administration on Friday finalized a major rule reshaping the ...

Read More

Eroding ACA Enrollment Portends Higher Insurance Rates

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s record enrollment. For ...

Read More

White House Adds Generic Drugs To Direct-To-Consumer TrumpRx Site

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx, in a bid to expand a platform that is key to his administration’s efforts to lower prescription drug costs in the U.S. The administration is adding more than 600 generic drugs to the site, President Donald Trump said at an event ...

Read More

Supreme Court Rejects Big Pharma Appeals Challenging Negotiated Drug Prices In Medicare

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. The court’s decision to deny ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square